Arcosa Future Growth
Future criteria checks 2/6
Arcosa is forecast to grow earnings and revenue by 8.8% and 8.6% per annum respectively. EPS is expected to grow by 7% per annum. Return on equity is forecast to be 6.9% in 3 years.
Key information
8.8%
Earnings growth rate
7.0%
EPS growth rate
Construction earnings growth | 24.2% |
Revenue growth rate | 8.6% |
Future return on equity | 6.9% |
Analyst coverage | Low |
Last updated | 10 Apr 2024 |
Recent future growth updates
Recent updates
Arcosa: Infrastructure Play Looking Sound
Apr 11What Arcosa, Inc.'s (NYSE:ACA) P/E Is Not Telling You
Apr 06Estimating The Fair Value Of Arcosa, Inc. (NYSE:ACA)
Feb 19Arcosa: A Good Business But Already Priced In
Feb 09Does Arcosa (NYSE:ACA) Have A Healthy Balance Sheet?
Feb 02Does Arcosa (NYSE:ACA) Deserve A Spot On Your Watchlist?
Jan 18Benign Growth For Arcosa, Inc. (NYSE:ACA) Underpins Its Share Price
Jan 03Calculating The Intrinsic Value Of Arcosa, Inc. (NYSE:ACA)
Nov 12Arcosa: Government Spending Is A Tailwind But Valuation Is High
Nov 03Arcosa (NYSE:ACA) Seems To Use Debt Quite Sensibly
Oct 05Do Arcosa's (NYSE:ACA) Earnings Warrant Your Attention?
Sep 14Arcosa: Some Warning Signs
Aug 10We Think Arcosa (NYSE:ACA) Can Stay On Top Of Its Debt
Jul 04Is Now The Time To Put Arcosa (NYSE:ACA) On Your Watchlist?
Jun 16We Think Arcosa (NYSE:ACA) Can Stay On Top Of Its Debt
Apr 02Here's Why We Think Arcosa (NYSE:ACA) Is Well Worth Watching
Mar 17Calculating The Fair Value Of Arcosa, Inc. (NYSE:ACA)
Mar 01Arcosa Non-GAAP EPS of $0.24 beats by $0.04, revenue of $500.3M beats by $23.65M
Feb 23Arcosa Q4 2022 Earnings Preview: Opinion Unchanged
Feb 17Does Arcosa (NYSE:ACA) Have A Healthy Balance Sheet?
Dec 29Arcosa declares $0.05 dividend, renews $50M stock buyback program
Dec 08Arcosa Should Sell Its Transportation Segment
Nov 16Calculating The Fair Value Of Arcosa, Inc. (NYSE:ACA)
Oct 20We Think Arcosa (NYSE:ACA) Can Stay On Top Of Its Debt
Sep 01Arcosa Non-GAAP EPS of $0.83 beats by $0.37, revenue of $602.8M beats by $55.67M
Aug 03Arcosa, Inc. (NYSE:ACA) Shares Could Be 32% Below Their Intrinsic Value Estimate
Jul 21Is Arcosa (NYSE:ACA) Using Too Much Debt?
May 17Arcosa: Challenges Will Likely Remain
May 16Is Arcosa, Inc. (NYSE:ACA) Trading At A 42% Discount?
Apr 06Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 2,743 | 188 | 135 | 355 | 5 |
12/31/2024 | 2,555 | 162 | 83 | 293 | 5 |
12/31/2023 | 2,308 | 159 | 58 | 261 | N/A |
9/30/2023 | 2,226 | 286 | -6 | 191 | N/A |
6/30/2023 | 2,238 | 282 | 36 | 218 | N/A |
3/31/2023 | 2,256 | 280 | 21 | 177 | N/A |
12/31/2022 | 2,243 | 245 | 36 | 174 | N/A |
9/30/2022 | 2,264 | 100 | 162 | 272 | N/A |
6/30/2022 | 2,220 | 91 | 130 | 227 | N/A |
3/31/2022 | 2,132 | 74 | 100 | 191 | N/A |
12/31/2021 | 2,036 | 69 | 81 | 167 | N/A |
9/30/2021 | 1,974 | 70 | 24 | 110 | N/A |
6/30/2021 | 1,904 | 78 | 111 | 191 | N/A |
3/31/2021 | 1,888 | 90 | 138 | 219 | N/A |
12/31/2020 | 1,936 | 106 | 178 | 260 | N/A |
9/30/2020 | 1,924 | 116 | 285 | 367 | N/A |
6/30/2020 | 1,879 | 118 | 248 | 338 | N/A |
3/31/2020 | 1,814 | 116 | 187 | 275 | N/A |
12/31/2019 | 1,737 | 112 | 273 | 359 | N/A |
9/30/2019 | 1,664 | 119 | 146 | 219 | N/A |
6/30/2019 | 1,598 | 90 | 91 | 154 | N/A |
3/31/2019 | 1,517 | 81 | 99 | 154 | N/A |
12/31/2018 | 1,460 | 76 | 74 | 119 | N/A |
9/30/2018 | 1,434 | 72 | 77 | 146 | N/A |
6/30/2018 | 1,421 | 89 | 103 | 174 | N/A |
3/31/2018 | 1,421 | 88 | 115 | 187 | N/A |
12/31/2017 | 1,462 | 90 | 80 | 162 | N/A |
12/31/2016 | 1,704 | 123 | N/A | 228 | N/A |
12/31/2015 | 2,140 | 135 | N/A | 293 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ACA's forecast earnings growth (8.8% per year) is above the savings rate (2.3%).
Earnings vs Market: ACA's earnings (8.8% per year) are forecast to grow slower than the US market (14.7% per year).
High Growth Earnings: ACA's earnings are forecast to grow, but not significantly.
Revenue vs Market: ACA's revenue (8.6% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: ACA's revenue (8.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ACA's Return on Equity is forecast to be low in 3 years time (6.9%).